The Value of Multigene Predictors of Clinical Outcome in Breast Cancer: An Analysis of the Evidence

Expert Review of Molecular Diagnostics - United Kingdom
doi 10.1586/14737159.2015.983476
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Commercialized Multigene Predictors of Clinical Outcome for Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2008English

An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers

Frontiers in Medicine
Medicine
2018English

Clinical Outcomes Based on Multigene Profiling in Metastatic Breast Cancer Patients.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Proliferation: The Most Prominent Predictor of Clinical Outcome in Breast Cancer

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2006English

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

A Multigene Predictor of Metastatic Outcome in Early Stage Hormone Receptor-Negative and Triple-Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2010English

Biological Rationale for a Patient-Specific Approach in the Treatment of Breast Cancer. Clinical Value of Novel Biomarkers of Breast Cancer

Tumors of female reproductive system
2019English

The Clinical Prognostic Value of Molecular Intrinsic Tumor Subtypes in Older Breast Cancer Patients: A FOCUS Study Analysis

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2015English

Clinical Value of Serum S100a8/A9 and CA15-3 in the Diagnosis of Breast Cancer

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy